<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Goncalves SV</submitter><funding>Versus Arthritis</funding><funding>Medical Research Council</funding><pagination>e1145</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10936964</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(2)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Sustained opioid use has long-term negative impacts on future pain experience, particularly in women. This study aimed to investigate the underlying spinal neurobiology of this clinical observation in an experimental model of joint pain.&lt;h4>Objectives&lt;/h4>In this study, we tested the hypothesis that sustained opioid treatment exacerbates chronic pain responses and alters spinal cord dorsal horn astrogliosis and the expression of GluN2B-containing N-methyl-d-aspartate receptors in female rats.&lt;h4>Methods&lt;/h4>Subcutaneous morphine (3 mg/kg) or saline was administered twice daily for 1 week before inducing a model of joint knee pain (intra-articular injection of 2 mg of monosodium iodoacetate [MIA]) in adult female Sprague-Dawley rats, with pain-free controls receiving 50 µL of saline. Pain behavior (weight-bearing and mechanical paw withdrawal thresholds) was measured at baseline and at intervals thereafter. Twice-daily morphine/saline treatment was continued for up to 3 weeks after intra-articular injections, and spinal cord tissue was collected for Western blot analyses.&lt;h4>Results&lt;/h4>Area under the curve analysis of weight-bearing asymmetry confirmed a significant exacerbation of pain behavior in the morphine/MIA group, compared with the saline/MIA group (F&lt;sub>(3,18)&lt;/sub> = 46.3, &lt;i>P&lt;/i> &lt; 0.0001), despite comparable joint damage in both groups. Sustained morphine treatment was associated with significant elevations in dorsal horn expression of astrocytic glial fibrillary acidic protein (27 ± 5% increase) and neuronal GluN2B (80 ± 30% increase), but not microglial IBA1, irrespective of the model of joint pain.&lt;h4>Conclusion&lt;/h4>These data suggest that sustained morphine treatment in female rats drives spinal cord plasticity, including spinal astrogliosis and the expression of GluN2B-containing N-methyl-d-aspartate receptors, priming the dorsal horn to incoming sensory inputs and producing exacerbated pain responses.</pubmed_abstract><journal>Pain reports</journal><pubmed_title>Sustained morphine exposure alters spinal NMDA receptor and astrocyte expression and exacerbates chronic pain behavior in female rats.</pubmed_title><pmcid>PMC10936964</pmcid><funding_grant_id>MR/W019663/1</funding_grant_id><funding_grant_id>20777</funding_grant_id><pubmed_authors>Chapman V</pubmed_authors><pubmed_authors>Goncalves SV</pubmed_authors><pubmed_authors>Hathway GJ</pubmed_authors><pubmed_authors>Woodhams SG</pubmed_authors><pubmed_authors>Li L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Sustained morphine exposure alters spinal NMDA receptor and astrocyte expression and exacerbates chronic pain behavior in female rats.</name><description>&lt;h4>Introduction&lt;/h4>Sustained opioid use has long-term negative impacts on future pain experience, particularly in women. This study aimed to investigate the underlying spinal neurobiology of this clinical observation in an experimental model of joint pain.&lt;h4>Objectives&lt;/h4>In this study, we tested the hypothesis that sustained opioid treatment exacerbates chronic pain responses and alters spinal cord dorsal horn astrogliosis and the expression of GluN2B-containing N-methyl-d-aspartate receptors in female rats.&lt;h4>Methods&lt;/h4>Subcutaneous morphine (3 mg/kg) or saline was administered twice daily for 1 week before inducing a model of joint knee pain (intra-articular injection of 2 mg of monosodium iodoacetate [MIA]) in adult female Sprague-Dawley rats, with pain-free controls receiving 50 µL of saline. Pain behavior (weight-bearing and mechanical paw withdrawal thresholds) was measured at baseline and at intervals thereafter. Twice-daily morphine/saline treatment was continued for up to 3 weeks after intra-articular injections, and spinal cord tissue was collected for Western blot analyses.&lt;h4>Results&lt;/h4>Area under the curve analysis of weight-bearing asymmetry confirmed a significant exacerbation of pain behavior in the morphine/MIA group, compared with the saline/MIA group (F&lt;sub>(3,18)&lt;/sub> = 46.3, &lt;i>P&lt;/i> &lt; 0.0001), despite comparable joint damage in both groups. Sustained morphine treatment was associated with significant elevations in dorsal horn expression of astrocytic glial fibrillary acidic protein (27 ± 5% increase) and neuronal GluN2B (80 ± 30% increase), but not microglial IBA1, irrespective of the model of joint pain.&lt;h4>Conclusion&lt;/h4>These data suggest that sustained morphine treatment in female rats drives spinal cord plasticity, including spinal astrogliosis and the expression of GluN2B-containing N-methyl-d-aspartate receptors, priming the dorsal horn to incoming sensory inputs and producing exacerbated pain responses.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2026-06-26T03:12:58.808Z</modification><creation>2026-06-26T03:08:10.963Z</creation></dates><accession>S-EPMC10936964</accession><cross_references><pubmed>38482044</pubmed><doi>10.1097/PR9.0000000000001145</doi></cross_references></HashMap>